Table 2.
Characterization of individuals by collection periods and stratification of groups according to sex and the following vaccines: ChAdOx1 nCoV-19, BNT162b2, and CoronaVac.
| Individuals by Collection Period. No (% in Relation to the Total) | Pre-Vaccine | 1 Month Post-Second Dose | 4–6 Months Post-Second Dose | 1 Month Post-Third Dose |
|---|---|---|---|---|
| ChAdOx1 nCoV-19 (n = 33) | 32 (96.9) | 31 (94) | 30 (91) | 26 (78.8) |
| Women (n = 23) | 21 (65.6) | 20 (64.5) | 19 (63.3) | 16 (61.5) |
| Men (n = 10) | 11 (34.4) | 11 (35.5) | 11 (36.7) | 10 (38.5) |
| BNT162b2 (n= 27) | 7 (25.9) | 26 (96.2) | 21 (77.7) | 20 (74.1) |
| Women (n = 11) | 2 (28.6) | 11 (42.3) | 10 (47.6) | 9 (45) |
| Men (n = 16) | 5 (71.4) | 15 (57.7) | 11 (52.4) | 11 (55) |
| CoronaVac (n= 18) | 1 (5.6) | - | 17 (94.4) | 10 (55.5) |
| Women (n = 15) | - | - | 14 (82.4) | 9 (90) |
| Men (n = 3) | - | - | 3 (17.6) | 1 (10) |
Abbreviations: n, quantity of individuals. In parentheses are represented the percentages.